Oral aspects and management of severe graft-vs-host disease in a young patient with beta-thalassemia: case report.
da Fonseca
M A
MA
Department of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, USA.
Schubert
M
M
Lloid
M
M
D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002327:Cariostatic Agents / Q000627:therapeutic use; D002648:Child; D002710:Chlorhexidine / Q000627:therapeutic use; D002908:Chronic Disease; D002921:Cicatrix / Q000209:etiology; D019140:Dental Care for Children; D017742:Dental Care for Chronically Ill; D005148:Facial Dermatoses / Q000209:etiology; D005459:Fluorides / Q000627:therapeutic use; D006086:Graft vs Host Disease / Q000209:etiology* / Q000628:therapy; D006801:Humans; D008297:Male; D009059:Mouth Diseases / Q000209:etiology* / Q000628:therapy; D009910:Oral Hygiene; D010859:Pigmentation Disorders / Q000209:etiology; D012594:Scleroderma, Localized / Q000209:etiology; D012871:Skin Diseases / Q000209:etiology; D014076:Tooth Diseases / Q000209:etiology* / Q000628:therapy; D017086:beta-Thalassemia / Q000628:therapy*
D000891:Anti-Infective Agents, Local; D002327:Cariostatic Agents; D005459:Fluorides; D002710:Chlorhexidine